345 related articles for article (PubMed ID: 29939889)
1. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Bibbins-Domingo K;
Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
[TBL] [Abstract][Full Text] [Related]
3. Effects of changing guidelines on prescribing aspirin for primary prevention of cardiovascular events.
Hissett J; Folks B; Coombs L; Leblanc W; Pace WD
J Am Board Fam Med; 2014; 27(1):78-86. PubMed ID: 24390889
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
; Davidson KW; Barry MJ; Mangione CM; Cabana M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Krist AH; Kubik M; Li L; Ogedegbe G; Pbert L; Ruiz JM; Stevermer J; Tseng CW; Wong JB
JAMA; 2022 Apr; 327(16):1577-1584. PubMed ID: 35471505
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease.
Shiffman D; Slawsky K; Fusfeld L; Devlin JJ; Goss TF
Clin Ther; 2012 Jun; 34(6):1387-94. PubMed ID: 22560621
[TBL] [Abstract][Full Text] [Related]
6. Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis.
Lotrionte M; Biasucci LM; Peruzzi M; Frati G; Giordano A; Biondi-Zoccai G
Prog Cardiovasc Dis; 2016; 58(5):495-504. PubMed ID: 26851562
[TBL] [Abstract][Full Text] [Related]
7. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
Hira RS; Kennedy K; Nambi V; Jneid H; Alam M; Basra SS; Ho PM; Deswal A; Ballantyne CM; Petersen LA; Virani SS
J Am Coll Cardiol; 2015 Jan; 65(2):111-21. PubMed ID: 25593051
[TBL] [Abstract][Full Text] [Related]
8. Aspirin in Older Adults: Need for Wider Utilization in Secondary Prevention and Individual Clinical Judgments in Primary Prevention.
Sehgal M; Wood SK; Ouslander JG; Hennekens CH
J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):511-513. PubMed ID: 28279072
[TBL] [Abstract][Full Text] [Related]
9. [The present status of aspirin use for primary prevention among hypertensive outpatients in China].
Liu J; Zhao D; Liu J; Qi Y; Sun JY; Wang W
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):267-72. PubMed ID: 27030613
[TBL] [Abstract][Full Text] [Related]
10. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
11. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women.
Rivera CM; Song J; Copeland L; Buirge C; Ory M; McNeal CJ
J Womens Health (Larchmt); 2012 Apr; 21(4):379-87. PubMed ID: 22303820
[TBL] [Abstract][Full Text] [Related]
12. Recent Evidence Examining Efficacy and Safety of Aspirin for Primary Cardiovascular Disease Prevention.
Carson E; Hemenway AN
Ann Pharmacother; 2019 Jul; 53(7):738-745. PubMed ID: 30654618
[TBL] [Abstract][Full Text] [Related]
13. A national survey on aspirin patterns of use and persistence in community outpatients in Italy.
Filippi A; Bianchi C; Parazzini F; Cricelli C; Sessa E; Mazzaglia G
Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):695-703. PubMed ID: 21450601
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of aspirin in primary prevention: is it time for a new approach?
Brotons C; Benamouzig R; Filipiak KJ; Limmroth V; Borghi C
Am J Cardiovasc Drugs; 2015 Apr; 15(2):113-33. PubMed ID: 25502483
[TBL] [Abstract][Full Text] [Related]
15. Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?
Selak V; Jackson R; Poppe K; Kerr A; Wells S
N Z Med J; 2018 Oct; 131(1484):19-25. PubMed ID: 30359352
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
